GSK has secured approval in China for Trelegy Ellipta as a maintenance treatment for adults with asthma, adding to its existing indication in COPD and making it the only single inhaler triple therapy ...
The Allergy Diagnostics and Therapeutics Market is thriving due to rising allergy prevalence and advancements in immunotherapy and diagnostics. Market growth is accelerated by technological ...
Researchers create Chinese Immune Multi-Omics Atlas, profiling more than 10 million immune cells and identifying 73 types of immune cells.
Dr. Geetika Sabharwal has been honored with a 2025 Global Recognition Award for her sustained contributions to allergy and ...
The house dust mite disease market is experiencing steady growth, driven by rising global prevalence of allergic rhinitis and asthma linked to indoor ...
The house dust mite disease market is experiencing steady growth, driven by rising global prevalence of allergic rhinitis and asthma linked to indoor allergens. Increasing adoption of allergen-specifi ...
Mrs Sutherland has missed so many family events and birthdays while in hospital or too sick to leave her home. Last year, she ...
11d
Novel immunotherapy demonstrates early potential to overcome resistance to immune checkpoint therapy
According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published in Nature Medicine, the novel monoclonal antibody linavonkibart has demonstrated the ...
When asked about food allergy management, more individuals reported choosing allergen avoidance over oral immunotherapy or ...
Entomon, currently recognised as the only company in Europe capable of extracting pure venom from Hymenoptera insects, produces pharmaceutical-grade insect venom using proprietary techniques (Entomon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results